Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel

SIMPLE SUMMARY: The combination of androgen deprivation therapy (ADT) with docetaxel (DX) or/and with novel anti-androgen receptor therapies have become standards for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). However, metastatic PC remains incurable, and bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez, Natalia, Reig, Òscar, Marín-Aguilera, Mercedes, Aversa, Caterina, Ferrer-Mileo, Laura, Font, Albert, Rodriguez-Vida, Alejo, Climent, Miguel Ángel, Cros, Sara, Chirivella, Isabel, Domenech, Montserrat, Figols, Mariona, González-Billalabeitia, Enrique, Jiménez Peralta, Daniel, Rodríguez-Carunchio, Leonardo, García-Esteve, Samuel, Garcia de Herreros, Marta, Ribal, Maria J., Prat, Aleix, Mellado, Begoña
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564355/
https://www.ncbi.nlm.nih.gov/pubmed/36230681
http://dx.doi.org/10.3390/cancers14194757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564355/
https://www.ncbi.nlm.nih.gov/pubmed/36230681
http://dx.doi.org/10.3390/cancers14194757

Ejemplares similares